Non Pharmacological Interventions For Mental Disorders

One of the side effects of the COVID-19 pandemic was the worsening of the symptomatology of mental disorders. The number of people with mental disorders has increased and pre-existing mental disorders have worsened, in many cases. Psychopharmacology alone is not sufficient for the treatment of conditions such as schizophrenia, depression, bipolar disorder, and generalized anxiety disorder, among others, and the combined use of psychopharmacology and non-pharmacological interventions is recommended by international guidelines. Despite this, most people around the world do not have access to non-pharmacological interventions and when they are diagnosed with a mental disorder, only psychopharmacological drugs are prescribed. In other cases, although non-pharmacological interventions, for example psychotherapy, are also prescribed, this response takes a long time.

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.

"The cerebrospinal vasculature originates at the aortic arch. The right brachiocephalic artery divides into the right common carotid artery and the right subclavian artery. The left common carotid and left subclavian arteries arise directly from the aortic arch. The 2 common carotid arteries bifurcate into the internal and external carotid arteries. The anterior circulation of the brain includes the distal branches from the internal carotid artery, including the anterior cerebral artery and the middle cerebral artery. The vertebral arteries arise from the subclavians and join at the pontomedullary junction, forming the basilar artery. The vertebrobasilar system and distal branches are commonly known as the posterior circulation of the brain"--

Bringing together treatment and referral advice from existing guidelines, this text aims to improve access to services and recognition of common mental health disorders in adults and provide advice on the principles that need to be adopted to develop appropriate referral and local care pathways.

Mental health and substance use disorders affect approximately 20 percent of Americans and are associated with significant morbidity and mortality. Although a wide range of evidence-based psychosocial interventions are currently in use, most consumers of mental health care find it difficult to know whether they are receiving high-quality care. Although the current evidence base for the effects of psychosocial interventions is sizable, subsequent steps in the process of bringing a psychosocial intervention into routine clinical care are less well defined. Psychosocial Interventions for Mental and Substance Use Disorders details the reasons for the gap between what is known to be effective and current practice and offers recommendations for how best to address this gap by applying a framework that can be used to establish standards for psychosocial interventions. The framework described in Psychosocial Interventions for Mental and Substance Use Disorders can be used to chart a path toward the ultimate goal of improving the outcomes. The framework highlights the need to (1) support research to strengthen the evidence base on the efficacy and effectiveness of psychosocial interventions; (2) based on this evidence, identify the key elements that drive an intervention's effect; (3) conduct systematic reviews to inform clinical guidelines that incorporate these key elements; (4) using the findings of these systematic reviews, develop quality measures - measures of the structure, process, and outcomes of interventions; and (5) establish methods for successfully implementing and sustaining these interventions in regular practice including the training of providers of these interventions. The recommendations offered in this report are intended to assist policy makers, health care organizations, and payers that are organizing and overseeing the provision of care for mental health and substance use disorders while navigating a new health care landscape. The recommendations also target providers, professional societies, funding agencies, consumers, and researchers, all of whom have a stake in ensuring that evidence-based, high-quality care is provided to individuals receiving mental health and substance use services.

The introduction of antipsychotic agents in the 1950’s substantially improved the treatment of schizophrenia and other psychotic disorders. However, clinical and functional outcomes are still far less than optimal for patients, and have not improved in recent years despite the development of several new antipsychotics. Efficacy rates are further compromised by medication non-adherence, which has been reported to affect more than half of patients. In response to these issues, several non-pharmacological interventions have been developed for the treatment of schizophrenia, such as cognitive behavioral therapy, cognitive remediation, social cognition training and metacognitive approaches. Although these interventions have produced promising results, there is still much controversy regarding their usefulness and applicability in clinical practice. A major impeding factor for their dissemination is possibly a lack of sufficient evidence regarding their specific indications, mechanisms of action, adverse effects, but also practical issues concerning the interpretability of respective clinical studies, such as the choice of outcome variables and control of confounding factors. The present Research Topic includes original research articles and reviews addressing these issues.

This title provides clinical considerations and guidelines for the clinician treating patients with pain and addiction. The text is structured in five sections that cover the core concepts of addressing pain and addiction; diagnosis and treatment; treating pain in patients with, or at risk for, co-occuring addiction; treating substance use disorders (SUD) and addiction in patients with co-occuring pain; and adapting treatment to the needs of specific populations. Each chapter ends with suggestions for further reading on the topics discussed

Like management of disease, management of pain is as old as the human race. When patients come to us with their pain, they present us with a wonderful opportunity: the chance to understand them, to understand how their pain is affecting their lives, the challenge of discovering what is causing their pain, and finally the opportunity to prescribe medications and lifestyle changes to help them gain relief from their pain. It is hoped that this book will provide the latest evidence-based updates on pain management in special circumstances and will serve as a ready reference for those embarking on pain management. Its intent is not to be a heavy book that can only be stored on a bookshelf, but a pocket-sized reference that can be carried, be easily navigated, and be available whenever a conceptual gap compromises pain physicians and their ability to treat their patients.